Furthermore, although several high-quality randomized-controlled trials only demonstrated equal or marginally significant advantages for csPCa detection by utilizing TP over TR biopsy in the TRANSLATE, PROBE-PC, PREVENT, and PERFECT trials (60% vs. 54%, 62% vs. 59%, 53% vs. 50%, and 47% vs. 54%, respectively) [ 35 ], the findings offer important insights.
← all excerpts
Performance of GPT-4 for automated prostate biopsy decision-making based on mpMRI: a multi-center evidence study.
1
—
—